PRMT5 and hepatocellular carcinoma: Although both transcripts were found to be overexpressed in tumors, the expression distribution of PRMT5 isoforms in HCC suggested that decreasing PRMT5-ISO1 and increasing PRMT5-ISO5 might be beneficial to HCC patients (Figure 1C and Figure S1A).